Artículo de la sección de clínica de la IUPHAR

International Union for Basic and Clinical Pharmacology (IUPHAR) Clinical Division considerations in the contextof COVID-19 pandemics.

IUPHAR Clinical Division: Caroline Samer (Switzerland), David Webb (UK), Guido Mannaioni (Italy), Hiroshi Watanabe (Japan), Jae Gook Shin (Korea), Jamie Coleman (UK), Maria Isabel Lucena (Spain), Matthew Doogue (NZ), Nilima Kshirsagar (India), Olayinka Ogunleye (Nigeria), Sarah Hilmer (Australia), Wei Wei (China).

Revisar: IUPHAR Clinical Division considerations in the context of COVID-19 pandemics_